JILLIAN MILLER: Open Payments
NPI 1710485461 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 25 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $501 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 9 | $224 |
| Merck Sharp & Dohme LLC | 6 | $149 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Exact Sciences Corporation | 2 | $53 |
| Biogen, Inc. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Genmab U.S., Inc. | 1 | $21 |
Products named: Lenvima, LYNPARZA, KEYTRUDA, JEMPERLI, The Cologuard Plus Collection Kit, ZURZUVAE, MONOFERRIC, Tivdak.
Industry payments across NY — which companies pay providers there.
